FDA NDC Directory · JSON-LD · Markdown
NDC 70710-1197 · HUMAN PRESCRIPTION DRUG · PATCH, EXTENDED RELEASE
| Labeler / Manufacturer | Zydus Pharmaceuticals USA Inc. |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA206318 |
| Dosage form / route | PATCH, EXTENDED RELEASE · TRANSDERMAL |
| Active ingredients | RIVASTIGMINE (9.5 mg/24h) |
| Marketing started | 20190306 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).